Dynamic angiographic imaging

Through dynamic angiography imaging technology, the image data of contrast agents in blood vessels is captured to generate a time enhancement curve, solving the shortcomings of CT coronary angiography technology in emergency medical and accuracy, and achieving rapid and accurate blood flow function evaluation.

CN112423660BActive Publication Date: 2024-11-08LONDON HEALTH SCIENCES CENTRE RESEARCH INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201980046802.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2018-05-17
Filing Date
2019-05-16
Publication Date
2024-11-08
Estimated Expiration
2039-05-16

AI Technical Summary

Technical Problem

Existing CT coronary angiography techniques require extensive post-processing and calculations in evaluating coronary stenosis, resulting in unsuitable medical emergency situations, and imaging-based FFR estimation and catheter measurements are less accurate, especially when the degree of stenosis increases. Reduced sexuality.

Method used

Through dynamic angiography imaging methods and systems, image data of the increase and decline phases of contrast agent in blood vessels is captured, and time-enhanced curves are generated to determine blood flow characteristics, such as blood flow reserve fraction (FFR), to replace traditional invasion Measurement method of sex.

Benefits of technology

It achieves rapid and non-invasive evaluation of vascular function, improves the accuracy and efficiency of FFR measurements, is suitable for medical emergencies, and maintains high diagnostic accuracy when the degree of stenosis increases.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN112423660B_ABST
    Figure CN112423660B_ABST
Patent Text Reader

Abstract

A computer-implemented method for dynamic angiographic imaging is described herein, comprising: obtaining image data, the image data comprising a plurality of corresponding images capturing at least a portion of both an increasing phase and a decreasing phase of a contrast agent in a vessel of interest; generating at least one time enhancement curve of the contrast agent based on the image data; determining blood flow characteristics in the vessel of interest based on the time enhancement curve. A system for implementing the method and a computer-readable medium incorporating the method are also described.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to dynamic imaging of blood flow, and more particularly to evaluating blood vessels within a subject based on dynamic imaging of contrast agent flow through the vessels. Background Art

[0002] The clinical gold standard for assessing the functional significance of coronary artery stenosis is the invasive fractional flow reserve (FFR) technique, in which a specialized catheter is advanced into the culprit artery with the aid of fluoroscopy to measure the blood flow pressure gradient across the plaque during periods of maximal hyperemia. Recently, noninvasive assessment of FFR using computed tomography coronary angiography (CCTA) images has emerged as a promising avenue for evaluating high-risk patients who require anatomical and functional assessment of coronary artery disease (CAD). However, currently, FFR assessment by CCTA requires extensive postprocessing and computation (typically exceeding several hours) and, therefore, is not currently suitable for assessing patients in emergency medical situations or settings. Furthermore, the DeFACTO and NXT trials reported that imaging-based estimates of FFR showed only moderate correlation (0.73) and diagnostic accuracy (approximately 80%) compared with catheter-based FFR measurements. A recent systematic review has revealed that the accuracy of FFR-CT measurements decreases with increasing stenosis severity when compared with gold standard catheter-based FFR measurements (Cook et al., (2017) Diagnostic accuracy of computed tomography-derived fractional flow reserve. A systematic review. JAMA; 2(7):803-810).

[0003] Therefore, there continues to be a need for alternative methods and systems for imaging-based assessment of blood vessels in a subject. Summary of the invention

[0004] In one aspect, a computer-implemented method for dynamic angiographic imaging is provided, comprising:

[0005] obtaining image data including a plurality of corresponding images that capture at least a portion of both a rising phase and a falling phase of contrast agent in a vessel of interest;

[0006] generating at least one time enhancement curve of the contrast agent based on the image data, the time enhancement curve having an upslope and a downslope;

[0007] The blood flow characteristics in the vessel of interest are determined based on the time enhancement curve.

[0008] In another aspect, a system for dynamic angiographic imaging is provided, comprising:

[0009] a memory for storing image data including a plurality of corresponding images capturing at least a portion of both a rising phase and a falling phase of contrast agent in a vessel of interest;

[0010] A processor is configured to generate at least one time enhancement curve of the contrast agent based on the image data, the time enhancement curve having an upslope and a downslope; and determine a blood flow characteristic in the vessel of interest based on the time enhancement curve.

[0011] In another aspect, a computer readable medium containing a computer program for dynamic angiographic imaging is also provided. BRIEF DESCRIPTION OF THE DRAWINGS

[0012] Figure 1 A schematic diagram of a dynamic angiographic imaging (DAI) system is shown.

[0013] Figure 2 A flow chart showing the DAI method.

[0014] Figure 3 Show Figure 2 Flowchart of pre-scan preparation in the DAI method shown in .

[0015] Figure 4 Show Figure 2 Flow chart of scanning data acquisition in the DAI method shown in .

[0016] Figure 5 Show Figure 2 Flowchart of time enhancement curve (TEC) generation in the DAI method shown in FIG.

[0017] Figure 6 Shown based on Figure 2 Flow chart of the DAI method for determining blood flow characteristics using TEC.

[0018] Figure 7 A flow chart showing a variant DAI method.

[0019] Figure 8 A general flow chart showing various example steps for determining blood flow characteristics and additional steps for improving the determination of blood flow characteristics.

[0020] Fig. 9 Shown are (a) velocity distribution of blood flow in a normal coronary artery; vectors (arrows) indicate the magnitude of flow velocity in each layer of blood flow; (b) tomographic slices for imaging the coronary artery; and (c) cross-sectional image of the lumen of a narrowed coronary artery covering a 2x2 pixel area.

[0021] Fig.10 Schematic diagram showing two tomographic slices A and B adjacent to a stenosis in a coronary artery; FA and F B Coronary blood flow in these slices is indicated respectively.

[0022] Fig.11 (a) The reference plane (dashed line) and lumen center in slices A and B in a straight vessel are shown; in this case, h A and h B is zero; and (b) a curved vessel, where the reference plane passes through center A but not through center B, so h A is zero, but h B Not zero (negative in this case).

[0023] Fig.12 Schematic diagram showing the ascending aorta and coronary arteries.

[0024] Fig.13 A graphical representation of the coronary arterial system is shown.

[0025] Fig.14 Shown from Fig.13 Schematic diagram of the three sides and their intersections of the diagram of the coronary artery system shown in .

[0026] Fig.15 Schematic diagram showing the correlation between the mass of contrast agent in a vessel segment and different time points of the corresponding measured temporal enhancement curve.

[0027] Fig.16 Shown ((a) and (b)) are contrast-enhanced CT cardiac images at rest and during vasodilation (dipyridamole) stress; (c) comparison of time enhancement curves (TECs) measured in the left aorta at rest (grey curve) and during maximal vasodilation stress (white curve); both TECs are aligned to the same start time to facilitate shape comparison.

[0028] Fig.17 Shown are ((a) and (b)) contrast-enhanced cardiac images at two slices where time enhancement curves in the left main artery (LM) and left anterior descending artery (LAD) were measured; ((c) to (e)) reformatted luminal views of the LM and LAD with the location of each ROI and the corresponding luminal diameter marked; (f) a three-dimensional rendered image of the heart with the approximate location of each ROI marked.

[0029] Fig.18 (a) shows the case without and with motion correction Fig.17Comparison of TEC measured in the distal LAD shown in b; ((b) and (c)) Cross-sectional views of the distal LAD to show the alignment of the vascular lumen before (b) and after (c) application of motion correction; TEC was measured in a 2x2 square pixel area, and a larger pixel area (20x20 pixels) was used to monitor the movement of the LAD at different time points for motion correction.

[0030] Fig.19 Contrast-enhanced cardiac images of patient 3 are shown at slices where the time enhancement curves in the LAD (a. before and during stenosis; b. after stenosis) and RCA (c. proximal; d. distal) and LCx (e. proximal; f. distal) were measured.

[0031] Fig. 20 Shown is a comparison of the time enhancement curves measured in Patient 3's (a) left anterior descending artery (LAD), (b) right coronary artery (RCA), and (c) left circumflex artery (LCx).

[0032] Fig.21 The FFR-CT images of the three coronary arteries of Patient No. 3 are shown; wherein the coronary segments where the FFR measurement is performed using the proposed dynamic angiography method are highlighted with dotted circles.

[0033] Fig. 22 Shown are ((a) and (b)) curvilinear reformatted views of the LAD with indicated plaque components; (c) a cross-sectional view of the LAD with indicated plaque components; ((d) to (f)) reformatted luminal views of the LAD with indicated locations of pre-stenotic, mid-stenotic, and post-stenotic segments and corresponding luminal diameters.

[0034] Fig.23 Shown are ((a) and (b)) two slices from contrast-enhanced images of Patient 1; (c) the locations of the two slices within the ascending aorta; ((d) and (e)) comparison of the time enhancement curves measured at two different slices in the ascending aorta.

[0035] Fig.24 The left coronary artery of Patient 2 is shown as shown in (a) a three-dimensional rendered image and (b) a curvilinear reformatted image of the heart.

[0036] Fig.25 Shown ((a) and (b)) are plaque occlusion in the RCA of Patient 4, and pre-plaque and post-plaque time enhancement curves generated from scan data acquired during (c) non-hyperemic or rest conditions and (d) hyperemic stress conditions.

[0037] Fig.26Shown ((a), (b), and (c)) are stent occlusion in the LCx of Patient 4, and pre- and post-stent time enhancement curves generated from scan data acquired during (d) non-hyperemic or rest conditions and (e) hyperemic stress conditions.

[0038] Fig. 27 Shown ((a), (b), and (c)) are plaque occlusions in the LAD of Patient 4, along with pre- and post-plaque time enhancement curves generated from scan data acquired during (d) non-hyperemic or resting conditions and (e) hyperemic stress conditions.

[0039] Fig.28 Shown are ((a) to (f)) time-sequential images of the porcine LAD acquired using invasive coronary angiography, and (g) graphs of contrast signal intensity versus frame number and (h) time enhancement curves.

[0040] Fig.29 Shown are ((a) to (f)) time-sequential images of the RCA of a pig acquired using invasive coronary angiography, and graphs of (g) contrast signal intensity versus frame number and (h) temporal enhancement curves.

[0041] Fig.30 Shown are MRI tomographic slices of (a) RCA and (b) LAD of a pig, and ((c) to (n)) time-sequential gadolinium-based T1-weighted images of the RCA (same slice positions as (a)). DETAILED DESCRIPTION

[0042] With reference to the accompanying drawings, a system and method for dynamic angiographic imaging (DAI) is described. The system and method compare advantageously with current CCTA techniques.

[0043] Figure 1 An example of a computer-implemented imaging system, more specifically, a DAI system 2, is shown, which includes a computed tomography (CT) scanner 4. The CT scanner 4 can be any multi-row or multi-slice CT scanner, which generally includes a radiation source, a radiation detector, and an adjustable, usually motorized support or table for maintaining a subject in a desired position (e.g., a prone or supine position) during a scanning procedure. The radiation source generates radiation that traverses one or more predetermined sampling sites synchronously with a contrast agent (also called a tracer) administered to the subject, which predetermined sampling sites are targeted to a blood vessel of interest in the subject. The radiation detector, which is often configured as a panel of a rotating detector, receives radiation that passes through the subject at the predetermined sampling sites, thereby providing projection data (also called scan data) over a time range that includes an increasing phase and a decreasing phase of contrast agent flowing through the blood vessel of interest.

[0044] The imaging system 2 includes a data acquisition component 6 that incorporates a data acquisition scheme or data acquisition computer code that receives, organizes and stores projection data from a radiation detector of a CT scanner. The projection data is sent to an image reconstruction component 8 that incorporates an image reconstruction computer code. The projection data can then be processed using the image reconstruction computer code to obtain image data that includes multiple images of predetermined sampling sites across both the increasing phase and the decreasing phase of the contrast agent flowing through the blood vessel of interest. The image reconstruction computer code can be easily changed to adapt to any available CT imaging technology. The image data can then be processed by an image analysis component 10 that incorporates an image analysis computer code that generates a time enhancement curve of the contrast signal from the image data. The time enhancement curve data can then be processed by a blood flow estimation component 12 that incorporates a blood flow estimation computer code to determine the blood flow value of the blood vessel of interest from the time enhancement curve data. The imaging system 2 is controlled by a computer 16, wherein data and operating commands are transmitted via a bus 14. The imaging system 2 may include any additional components as needed to evaluate the vessel of interest, including multiplexers, digital / analog conversion boards, microcontrollers, physical computer interface devices, input / output devices, display devices, etc. The imaging system 2 is shown with only a CT scanner as an illustrative example, and the system may be modified to include other imaging modalities, including, for example, X-ray imaging and magnetic resonance imaging (MRI) in addition to CT.

[0045] Figure 2 A computer-implemented method 20 for DAI is shown. The method 20 includes pre-scan preparation 30 and positioning a subject for a CT scan of a desired sampling site. Once the subject is prepared and positioned in the CT scanner, a contrast solution is injected 40 into the subject, and a CT scan 50 is performed synchronously with the injection of the contrast solution to acquire projection data (also referred to as scan data) over a period of time including contrast agent flowing through a blood vessel at the sampling site. The projection data is processed to reconstruct 60 image data from the projection data. The image data is analyzed to generate 70 a time enhancement curve of a contrast signal parameter (such as contrast signal intensity) extracted from the image data. A blood flow value is calculated 80 based on the time enhancement curve.

[0046] Figure 3An example of pre-scan preparation 30 of a subject for a CT scan is shown. Pre-scan preparation 30 includes identifying a region of interest 32 within the subject. For example, the region of interest may be a portion of a vessel targeted for evaluation of blood flow in the vessel. Once the region of interest is established, a sampling site for a CT scan slice is identified 34 at or near the region of interest. Based on the predetermined sampling site, the subject is positioned 36 in the CT scanner in an alignment that allows a radiation source of the CT scanner to direct radiation at the sampling site. Prior to the scan, a hyperemic condition may be induced 38 within the subject, for example, by administering a vasodilator to the subject.

[0047] Figure 4 An example of a CT scan 50 synchronized with the injection of contrast agent is shown. The synchronized CT scan 50 includes starting a dynamic CT scan at a desired time based on the injection of contrast agent. The dynamic CT scan includes acquiring projection data before contrast agent enters 54 at the sampling site, acquiring projection data during an increasing phase 56 of contrast agent at the sampling site, and acquiring projection data during a decreasing phase 58 of contrast agent at the sampling site. The increasing phase refers to the increase in the mass of contrast agent at the sampling site over time after the contrast agent initially enters the sampling site, while the decreasing phase or decreasing phase refers to the decrease in the mass of contrast agent at the sampling site over time before the contrast agent is substantially completely cleared from the sampling site. During the progression from the increasing phase to the decreasing phase, the peak (maximum) mass of contrast agent at the sampling site occurs. The time elapsed from the entry of contrast agent at the sampling site to its clearance can be referred to as the transit time of the contrast agent. The duration of the CT scan is not limited by the requirement to capture the complete transit time of contrast agent at the sampling site, as long as at least a portion of both the increasing phase and the decreasing phase are captured. Projection data acquired prior to the entry 54 of contrast agent may provide reference values ​​during subsequent image analysis that may be used to normalize contrast agent signal values ​​determined for the ramp-up and ramp-down phases.

[0048] Figure 5An example of image analysis to generate 70 a time enhancement curve is shown. Generation of the time enhancement curve may include identifying 72 a vessel of interest within a plurality of corresponding images at two sampling sites spanning both an increasing phase and a decreasing phase of contrast agent at the sampling sites. Contrast agent signal data, such as contrast agent signal intensity, is extracted 74 from each of the plurality of corresponding images from a region defined by the vessel of interest. The time enhancement curve is generated 74 based on the contrast agent signal data during both the increasing phase and the decreasing phase at the sampling sites. If image data prior to contrast agent entry at the sampling sites is available, a reference value may be determined to generate the time enhancement curve based on a standardized contrast agent signal value. In an alternative for determining the reference value, scan data prior to contrast agent entry may be acquired before or after a contrast agent administration event. As another alternative, a reference value for normalizing the time enhancement curve may be extracted from image data reconstructed from scan data acquired after clearing contrast agent at the sampling sites. In these alternatives, determining the reference value from scan data acquired after the administration event and prior to entry is typically accomplished within a shorter scan duration. Although the time enhancement curve is generated based on scan data acquired during both the ramp-up phase and the ramp-down phase, the time enhancement curve may alternatively be based on scan data acquired at the sampling site at various time points relative to the contrast agent delivery time, including, for example, before contrast agent enters the sampling site, at the peak (maximum) of contrast agent at sampling, and after contrast agent is cleared from the sampling site.

[0049] Figure 6 An example of estimating blood flow 80 in a vessel of interest based on a time enhancement curve is shown. Estimation of blood flow can be achieved by determining a fractional flow reserve (FFR) value based on the time enhancement curve. Determination of the FFR value may include calculating an area 82 under the time enhancement curve. The flow rate 84 may be determined based on the calculated area under the time enhancement curve, for example using the indicator dilution principle expressed in Equation 1 (provided below as an illustrative mathematical basis for the DAI method). The flow rate 85 may be determined based on the flow rate and the calculated cross-sectional area of ​​the lumen of the vessel at the sampling site, for example using Equation 2 (see below). The flow pressure 86 may be determined from the flow rate, for example using the Bernoulli equation as shown in Equation 3A or 3B (see below). Based on the flow pressure 86 determined from at least two sampling sites, a pressure gradient may be calculated, and the FFR value may be determined based on the calculated pressure gradient and the systolic blood pressure value, for example using Equation 11 (see below). The determined FFR value may be communicated or displayed to a technician / operator or other end user by any conventional computer or display device.

[0050] The DAI system and method have been mathematically validated.The mathematical analysis described in the following paragraphs shows an example of deriving blood flow characteristics in the coronary arteries from contrast-enhanced images of the heart acquired by dynamic imaging. Figure 8 A flow chart is provided showing an overview of the relationship of various examples (Example 1, 2, 3 or 4) of blood flow characteristic determination and examples of additional supplementary steps (Supplementary Steps 1, 2, 3 or 4) to further improve the blood flow characteristic determination. A detailed description of each example and each supplementary step for calculating blood flow characteristics is provided in the following sections. The following mathematical analysis is for illustrative purposes only, without wishing to be bound by theory, and is not intended to be a limiting description.

[0051] Mathematical Analysis: Assumptions. Several assumptions can be made about the properties of blood circulation in the coronary system during DAI. First, blood is considered to be a Newtonian fluid with a linear relationship between shear stress and shear rate; second, under normal conditions, blood flow is laminar, where blood moves in parallel layers within the lumen of the vessel. The layers at the surface of the arterial wall are stationary (velocity = 0), while the layers at the center of the lumen exhibit the highest velocity ( Fig. 9 a). In fact, the blood flow measured at the region of interest within the coronary artery is approximately equal to the average flow / velocity around the center; third, the tracer (also called contrast agent; for example, iodine molecules in CT contrast agents) does not leak through the endothelial cell layer of the coronary artery into the surrounding extravascular space during its passage through the artery; fourth, at the current CT spatial resolution, the smallest coronary arteries for which blood flow can be reliably estimated using the proposed method are those with a diameter greater than 1.5 mm. This is roughly equivalent to a 2x2 pixel area in a CT image ( Fig. 9 b and Fig. 9 c).

[0052] Mathematical analysis: equation symbols. A summary of equation symbols used in the mathematical analysis is provided in Table 1. The units listed in Table 1 are not necessarily SI units.

[0053] Table 1. Summary of equation symbols.

[0054]

[0055]

[0056] Mathematical analysis: Figure 8 Methods in Example 1 - Calculation of coronary blood flow. Coronary blood flow is measured using the indicator dilution principle, which states that the extent to which tracer molecules (CT contrast agents) mix with the blood after a bolus injection depends on the volume flow of the blood. Mathematically, it can be expressed as:

[0057]

[0058] where F is the volume flow of blood (in mL / s), Q is the total mass of tracer in the coronary artery (in mg), and C a (u) is the tracer concentration in arterial blood at time u (in mg / mL). a The integral of (u) can be obtained from the arterial time enhancement curve ( Figure 8 Q is determined by the area beneath the TEC in the coronary artery, provided that the correct conversion from contrast enhancement (in Hounsfield units or HU) to contrast concentration (in mg / mL; 1 mg / mL ≈ 25 HU when the scan is set to 100 kV tube voltage) is made. Q is derived from a two-step process: first, the total mass of iodine injected into the patient is calculated, which is equal to the product of the contrast agent concentration and the injection volume; second, the percentage of iodine that enters the coronary system is estimated using published values ​​or information presented in dynamic perfusion images.

[0059] Mathematical analysis: Figure 8 Methods in Example 2 - Calculation of coronary flow pressure. To estimate the flow pressure difference across a coronary stenosis, coronary blood flow is measured before / upstream and after / downstream of the stenosis of interest. Fig.10 , which depicts two sample slice locations A and B adjacent to a stenosis in a coronary artery. At each slice location, the coronary blood flow F can be calculated using Equation 1. Once F is calculated A and F B , the volume flow rate F can be converted into flow velocity V as follows:

[0060]

[0061] Where V is the flow velocity in cm / s and r is the radius of the vessel in cm. The Bernoulli equation can then be used to estimate the flow pressure difference across the stenosis:

[0062]

[0063]

[0064] Among them, P A and P B are the coronary flow pressure in slices A and B, respectively (in Pascals or Pa), and ρ is the blood density (g / cm 3 ), g is the Earth's gravity (980 cm / s 2 ), h A and h B is the relative height (in cm) above or below the reference plane from the center point in slices A and B, and P L is the pressure (energy) loss due to friction and / or turbulence (see Eq. 4).

[0065] The fundamental basis of Bernoulli's principle is the conservation of energy. The first term on both sides of equation 3A can be thought of as the pressure energy per unit volume, the second term as the kinetic energy per unit volume, and the third term as the potential energy per unit volume. A and h B This can be simplified by appropriate choice of reference plane. If the reference plane is chosen to be a plane passing through the center of the lumen in slices A and B, as Fig.11 a, then both potential energy terms in the equation are equal to zero (i.e. h A and h B = 0). However, if there is a vertical gradient between the two centers (as in the case of coronary anatomy) ( Fig.11 b), the height difference between the two centers must be taken into account. A plane passing through center A can be chosen as the reference plane, so that h A is always zero, and for simplicity, the potential energy term associated with slice A (ρgh A ). Note that if center B is higher than center A, then h B is positive and vice versa.

[0066] Pressure loss P L Mainly caused by the friction caused by the movement of viscous blood along the blood vessels (P LF ) and, to a lesser extent, by vortices (swirls) generated by the sudden expansion in the lumen as flow moves from a stenotic to a normal coronary segment (P LE ):

[0067] P L ≈P LF +P LE (4)

[0068] P can be estimated using the Darcy-Weishbach equation LF Size:

[0069]

[0070] where L is the distance between slices A and B (in cm), D is the diameter of the artery (in cm), and V is given by equation (2) and is the average flow velocity between slices A and B. The Darcy friction factor f is a dimensionless quantity and is given by the Churchill equation:

[0071]

[0072] in, and Where Re is the Reynolds number that predicts the flow behavior (laminar vs. turbulent) and ε is a roughness index that describes the surface texture of the pipe in which the fluid flows. Blood vessels are assumed to be smooth pipes, and therefore ε is zero. The Reynolds number is given by:

[0073]

[0074] Where μ is the blood viscosity in Pa·s or kg / m·s or g / cm·s. Alternatively, the Darcy friction factor can also be estimated using the following equation:

[0075] For laminar flow:

[0076] For turbulent flow: When ε = 0 (9) Equation (9) is also called the Colebrook equation. The choice of equation (8) or (9) depends on the flow behavior (laminar vs. turbulent), which can be estimated using the Reynolds number obtained from equation (7). Typically, when Re < 2000, the blood flow is completely laminar, and when Re > 4000, the blood flow is completely turbulent. P in equation (4) LE The size can be estimated as:

[0077]

[0078] Where V1 and V2 are the flow velocities in the narrowed segment and the adjacent normal segment (outlet), respectively. Another factor that may contribute to the smaller pressure loss is the flow entry from the larger vessel to the smaller vessel. Since the loss coefficient associated with the rounded (non-sharp) conduit entrance is very small (0.04), the smaller pressure loss due to the flow entry can be considered negligible compared to the smaller pressure loss due to the sudden lumen expansion (as described in Eq. (10)).

[0079] To correctly apply the Bernoulli equation, the units in each term should be consistent with the other terms. All energy terms in the equation (pressure, kinetic energy, and potential energy) should have units (g·cm 2 ·s -2 ) / cm 3 The unit of pressure is Pascal, which can be converted into the following units: 1Pa = 1kg / m·s 2 =1000g / 100cm·s 2 =10g / cm·s 2 . In the estimated g / cm·s 2 After having obtained the pressure gradient ΔP in units, we can then convert it to conventional mmHg units with a multiplication factor of 0.0075 (1 Pa = 0.0075 mmHg).

[0080] Mathematical analysis: Figure 8 Method Example 3 - Calculation of Fractional Flow Reserve.The fractional flow reserve (FFR) can be derived from ΔP in equation (3b). In routine clinical practice, it is assumed that P A This is the same as the systolic blood pressure (SBP) which can be obtained from mean arterial pressure measurements. Therefore, FFR can be estimated by the following equation:

[0081]

[0082] Mathematical analysis: Figure 8 Methods in Example 4 - Calculation of shear stress. from Figure 8 From the blood flow measurements in Example 1, wall shear stress can also be estimated. Wall shear stress is the shear force applied to the surface of the arterial wall by the blood flow. This parameter may be useful for predicting the vulnerability of plaques formed on the wall surface of the artery. Blood moves in parallel layers in the blood vessel due to its laminar behavior, where the flow velocity at the surface of the vessel wall is equal to zero. The shear rate describes the rate at which different blood layers move past each other, and the wall shear rate specifically refers to the rate at which the blood layer of interest moves relative to the blood layer at the wall surface with zero velocity. If the blood layer of interest passes through the center of the blood vessel lumen, the wall shear rate γ (in s -1 The unit is given by the following formula:

[0083]

[0084] Where r is the radius of the vessel (the distance between the central layer and the wall surface), V is the velocity of the central blood layer relative to the wall surface, and F is the volume flow rate of blood at the center of the vessel. In practice, blood flow is measured in an area that covers more than just the center of the vessel, and for simplicity, the measurement can be approximated as the average flow or velocity at the center. Since blood is a Newtonian fluid, its shear rate is linearly related to the shear stress:

[0085] τ=μ·γ (13)

[0086] Where τ is the shear stress in Pascals (Pa), and μ is the blood viscosity in g / cm·s. Both viscosity and density can be measured by blood tests rather than using published values ​​for an average adult to improve the accuracy of calculations for individual patients.

[0087] Mathematical analysis: Figure 8 Supplementary step 1 of the method - Quality of the tracer entering the coronary circulation from the aorta Estimates. Coronary blood flow (F) is estimated from equation (1), which requires a priori knowledge of the mass (Q) of the tracer. After bolus injection into a peripheral vein (e.g., antecubital vein), all tracers are delivered to the ventricles, where they are homogeneously mixed and ejected into the ascending aorta. Therefore, the amount of tracer delivered to each organ via arterial blood can be estimated from the ratio of organ blood flow to total cardiac output. For example, blood flow in the heart is approximately 5% of cardiac output, so we can assume that 5% of the injected tracer is delivered to the coronary arteries.

[0088] This section presents complementary steps where the information present in the dynamic perfusion images can be used to estimate the mass of the tracer in the coronary system. The use of patient-specific information can allow for more accurate measurements of coronary flow and pressure for individual patients.

[0089] Unlike most vascular beds in the body, blood flow in the coronary arteries is greatest during diastole rather than systole. During diastole, the left ventricle continues to relax, resulting in a significant reduction in aortic pressure and aortic return flow. At the same time, compression of the coronary microcirculation in the myocardium is relieved. As a result, regurgitation (e.g., backward-propagating suction) occurs, which promotes filling of the coronary arteries. Therefore, regurgitation in the aorta together with a reduction in coronary resistance results in maximal coronary blood flow during diastole. In dynamic myocardial perfusion imaging, contrast-enhanced cardiac images are acquired at successive diastole phases to minimize cardiac motion, and therefore, the aortic blood flow observed in these dynamic images is retrograde (backward) flow rather than antegrade (forward) flow. The direction of flow is as shown in Figure 2. Fig.12 shown.

[0090] Consider Fig.12 Two tomographic slices in the ascending aorta are shown. Slice 1 (S1) is located just above the ostium and aortic valve, and slice 2 (S2) is above S1 but a few centimeters below the aortic arch ( Fig.12 The blood flow in each slice can be estimated using the indicator dilution principle shown in equation (1):

[0091]

[0092]

[0093] where F1 and F2 are the volume flow rates in slices 1 and 2, respectively (in mL / s), Q1 and Q2 are the masses of the tracers in slices 1 and 2, respectively (in mg), and C al (u) and C a2 The integral of (u) is the area under the time enhancement curve measured from time 0 to t in slices 1 and 2, respectively. Considering the fact that the aortic blood flow is very fast and the two slices are relatively close to each other, it can be assumed that the blood flow in the two slices is the same, that is, F1 = F2. Combining equation (1a) and equation (1b) yields:

[0094]

[0095] or

[0096] Equation (14) describes the fraction of tracer in slice 1 relative to that in slice 2. Since some tracer passes through slice 2 and enters the coronary arteries before reaching slice 1, Q1 should be less than Q2. Since blood flow in the heart is approximately 5% of cardiac output, approximately 5% of the tracer that leaves the heart should end up in the coronary circulation. If the tracer exiting the heart is evenly distributed along the aorta, then Q1 / Q2 should be approximately equal to 0.95 (Q1 is approximately 95% of Q2. See experimental test example).

[0097] Mathematical analysis: Figure 8 The method supplements step 2 - estimation of the mass of the tracer in a single coronary artery. Similar to Figure 8 In addition to the mathematical treatment of step 1 in FIG. 1 , this section describes a method for estimating the mass of tracer in each epicardial coronary artery based on information present in dynamic perfusion images. A graphical representation of the coronary artery system may be useful to supplement the description of step 2. The vascular system of any organ, such as the coronary artery system in the heart, may be represented by a graph having a plurality of edges and vertices, such as Fig.13 shown.

[0098] A vertex (v) can be thought of as an intersection that connects two (or more) vessels together, while an edge (E) can be thought of as a vessel that connects two vertices together. Mathematically, Fig.12 The graph shown in can be represented as:

[0099] v={v1,...,v n}, where n=10;

[0100] E={{v1, v2}, {v2, v3}, {v3, v4}, {v5, v6}, {v6, v7}, {v7, v8}, {v6, v9}, {v9, v 10}}. This graph is a directed graph, where the net flow in each edge is in one direction only (not bidirectional). The flow generally moves away from the source (the aorta, as represented by the dark gray cylinder in the figure). Each edge is assigned a number based on the American Heart Association's coronary artery model (as shown in Table 2):

[0101] Table 2. Numbering model of the coronary arteries.

[0102] 1- Proximal right coronary artery (RC) 9-First diagonal 2-Intermediate RC 10- Second diagonal 3-Remote RC 11-Proximal left circumflex artery (LCx) 4-Posterior descending branch 12-Obtuse marginal branch 5-Left main coronary artery (LM) 13- Distal LCx 6-Proximal left anterior descending artery (LAD) 14-Posterolateral 7- Middle LAD 15-Posterior descending branch 8- Distal LAD

[0103] To illustrate how to estimate the distribution of tracer in each coronary artery, consider three edges: 5, 6, and 11, which represent the LM and proximal LAD and LCx, respectively. Edge 5 is the "parent" vessel of edges 6 and 11, and edges 6 and 11 are the "children" vessels of edge 5. These vessels are connected at vertex 6 (v6). Fig.14 A schematic diagram showing three edges and their intersections is shown.

[0104] The direction of flow in each vessel is Fig.14 The segments near the inlet of each vessel are highlighted in dark grey. The radius (r) and length (l) of each segment are marked with a subscript (n) equal to the side number of the vessel. The volume of each segment ( ) are given by the following formula:

[0105]

[0106] To avoid confusion, “V” stands for velocity (cm / s); “v” stands for apex (crossing); Represents the volume of the vessel segment. The volume of each segment is in cm 3 The unit can be converted to mL.

[0107] Consider the two highlighted segments in edges 5 and 6. Fig.15 As shown, all tracers (represented by gray in the blood vessels) are expressed at the time corresponding to the peak of the time enhancement curve measured in this segment (T = t3, Fig.15 ) remain in this segment. The maximum value (peak value) of the time enhancement curve has the unit of HU (Hounsfield Unit) and can be converted to (mg / mL).

[0108] Therefore, the total mass of tracer (Q, in mg) in a given segment of a vessel can be estimated by multiplying the maximum value (peak value) of the time enhancement curve measured in that segment (x, in mg / mL) by the volume of that segment:

[0109]

[0110] where n is the edge number. The fraction of tracer from edge 5 (LM) to edge 6 (LAD) can be calculated by taking the ratio of Q6 to Q5:

[0111]

[0112] If the length of each segment is the same, i.e., 15=16, then equation (17) can be further simplified to:

[0113]

[0114] Equation (18) is equal to the fraction of tracer distribution in LAD relative to LM. Similarly, the fraction of tracer distribution in LCx relative to LM is given by:

[0115]

[0116] All tracer that leaves the LM must be delivered to the LAD or LCx (in the absence of an intermediate branch). Therefore, due to the conservation of mass of the tracer in the vasculature, the following equation holds:

[0117]

[0118] Substituting equations (18) and (19) into (20) yields:

[0119]

[0120] Mathematical analysis: Figure 8 The method in Supplementary Step 3 - Motion Correction of Temporal Enhancement Curves. Time enhancement curve (TEC) measurements can be affected by residual motion in the coronary arteries. This section describes a set of criteria that can be used to minimize motion-induced TEC fluctuations to improve TEC accuracy and facilitate accurate coronary flow and pressure assessment:

[0121] 1. The TEC in the proximal segment of the coronary artery can be measured using a larger pixel area to maximize the signal-to-noise ratio of the curve. This high-quality TEC can be used as a reference curve to constrain the shape of the TEC measured in the distal segment of the same artery (see criteria 2 and 3 below).

[0122] 2. Since each epicardial coronary artery has only one entry point, the contrast arrival time of the distal (downstream) TEC cannot be shorter than the contrast arrival time of the proximal (upstream) TEC measured in the same coronary artery. The contrast arrival time refers to the time interval between t=0 (first dynamic image coordinated at or near the time of bolus injection) to the moment when the tracer (contrast agent) arrives in the artery (contrast enhancement begins).

[0123] 3. Due to the single inlet port in each epicardial coronary artery, the area under the distal (downstream) TEC cannot be larger than the area under the proximal (upstream) TEC, since the area under the curve (AUC) in a coronary segment is related to the total mass of tracer passing through that segment.

[0124] 4. First identify the time point corresponding to the maximum contrast enhancement in the coronary artery. It is used as a reference time point to track the position of the same artery at all other time points.

[0125] 5. In each slice, a small pixel region (e.g. 2x2 pixels) is used to cover the artery of interest at a reference time point (criterion number 4). This pixel region is then used to search for the same segment of the artery within a larger search region (e.g. 20x20 pixels) in the same slice at other time points.

[0126] 6. For time points where the artery of interest is not obvious in the slice due to motion, the search area in criterion No. 5 is extended to one adjacent slice upstream (above) and one adjacent slice downstream (below) at the corresponding time point (the scan can capture 3D image data of all or part of the blood vessel, and the 3D image data can be divided into multiple slices so that the adjacent slice upstream (above) and the adjacent slice downstream (below) are easily obtained to compensate for the missing artery of interest at that time point). If the artery is still missing or significantly blurred due to intense motion, linear interpolation is applied to estimate the missing contrast enhancement value in that segment of the artery at that time point of the time enhancement curve. The reference curve from criterion No. 1 can be used to ensure that the interpolated pixel values ​​do not result in violations of criteria No. 2 and No. 3.

[0127] Mathematical analysis: Figure 8 Supplementary step 4 of the method - Assessment of the effect of bolus injection of tracer. Although all tracer injected into a peripheral vein should be delivered to the heart, intravenous bolus injection may not be optimal due to technical problems (e.g., pump failure, poor needle positioning, or vasoconstriction) and, therefore, overestimation of the mass of tracer in the coronary system. This section describes a method that can be used to assess the efficacy of tracer injection based on the information present in dynamic contrast-enhanced images.

[0128] First, the time enhancement curve (TEC) in the superior vena cava (SVC) is measured from dynamic images. The SVC is the first path for the tracer to enter the heart and close to the intravenous injection site. Therefore, the tracer present in the SVC should be minimally diluted or dispersed. Once the TEC is measured from the SVC, the area under the curve is calculated before applying the indicator dilution principle (Equation (1)) to estimate the blood flow in the SVC. The average blood flow in the SVC of an adult is approximately 1800 to 2000 mL / min. If the calculation of the SVC blood flow is comparable to the published value, it can be determined that all the tracer has been correctly injected into the peripheral veins. In contrast, if most of the tracer is not correctly injected into the vein, the TEC curve measured in the SVC should have a much smaller area under the curve, and therefore lead to a serious overestimation of the SVC blood flow.

[0129] The DAI system and method have been validated by experimental testing. The experimental test results demonstrate the ability of the DAI system and method to determine one or more of several blood flow characteristics. The following experimental examples are for illustrative purposes only and are not intended to be limiting descriptions.

[0130] Experimental example: Experimental example 1. The results of Experimental Example 1 are consistent with those from Figure 8 The use of the mathematical method described in Example 1 is related.

[0131] (a) Patient and scan information. Patient 1 was a 62-year-old female weighing 51 kg. She underwent both rest and stress CT myocardial perfusion imaging. Intravenous infusion of dipyridamole induces a congestive state. For each imaging study, 36 mL of iodinated contrast medium was injected at a contrast concentration of 350 mgI / mL (dose: 0.7 mL per kg body weight). Dynamic imaging of 120 mm of the heart was performed in the middle of 30 diastole periods using a 256-line / 160 mm clinical CT scanner at a tube voltage of 100 kV, a tube current of 100 mA, and a rack rotation speed of 280 ms with breath holding.

[0132] (b) accompanying drawings. Fig.16 a and Fig.16 b shows contrast-enhanced images of the heart acquired at rest and during maximal vasodilation stress, respectively, at a slice location where the left aorta is seen. Fig.16 The time enhancement curve measured from the left aorta before (arrow in a / b) Fig.16 Shown in c.

[0133] (c) Results. CT coronary angiography (CCTA) revealed that there was no stenosis in all coronary arteries, including the left main artery. Corresponding myocardial perfusion measurements performed with SPECT (single photon emission computed tomography) and CT showed no myocardial ischemia. The AUC (area under the curve) of the left main TEC at rest and stress was 3104.87 and 1350.35 HU·s, respectively. The corresponding coronary blood flows at rest and stress were 100.61 and 231.33 mL / min, respectively. The ratio of stress coronary blood flow to resting coronary blood flow (i.e., coronary flow reserve) was 2.31.

[0134] (d) Interpretation. It is known that in nonischemic myocardium, coronary blood flow can increase 2- to 4-fold from baseline during maximal coronary vasodilation. Our data show that the increase in coronary blood flow from baseline measured by our method is consistent with the expected range for normal coronary artery territories. Therefore, the results of this study indicate that our method can reliably measure resting and hyperemic coronary blood flow.

[0135] Experimental example: Experimental example 2. The results of Experimental Example 2 are consistent with those from Figure 8 Examples 1 to 3 are related to the use of the mathematical methods described.

[0136] (a) Patient and scan information. Patient 2 was a 62-year-old female weighing 60 kg. She was given 140 μg kg -1 ·min -1Patients underwent stress CT myocardial perfusion imaging with intravenous infusion of adenosine (vasodilator) at a rate of 1.5 s.l. During the imaging study, 43 mL of iodinated contrast medium was injected at a contrast concentration of 320 mgI / mL (dose: 0.7 mL per kg body weight). Dynamic imaging of 120 mm of the heart was performed in the middle of 22 diastole periods using a 256-line / 160 mm clinical CT scanner at a tube voltage of 100 kV, a tube current of 100 mA, and a gantry rotation speed of 280 ms. The patients held their breath throughout the imaging study. The mean arterial pressure recorded at 3 minutes of adenosine infusion was 132 / 78 mmHg.

[0137] (b) the accompanying drawings. Fig.17 a and Fig.17 b shows contrast-enhanced cardiac images at two axial slices to demonstrate the locations where TEC was measured in the left aorta (LM, ROI 1) and in the proximal (ROI 2) and distal (ROI 3) LAD. The slice locations were 60 mm apart. Fig.17 c. Fig.17 d and Fig.17 e shows a reformatted luminal view of the LAD to show Fig.17 a and Fig.17 The position of each ROI is shown in b. The lumen diameter at each position is also marked. Fig.17 f shows a three-dimensional rendered image of the heart with the approximate location of each ROI. Fig.18 TEC ( Figure 8 Supplementary step 3).

[0138] (c) Results. CCTA showed no stenosis in the LM and LAD arteries. The FFR in the proximal and distal segments of the LAD were 0.99 and 0.92, respectively. The findings are summarized in Table 3.

[0139] Table 3. Summary of physiological measurements in the LAD artery of patient 2.

[0140]

[0141] (d) Interpretation. Given the high sensitivity and negative predictive value of CCTA, we determined that the LM and LAD arteries were normal (no stenosis). FFR measurements performed with our method showed that there was no significant decrease in blood flow pressure along the LAD artery, which was consistent with the anatomical assessment by CCTA. In addition, the coronary blood flow during maximum vasodilation (>330 mL / min) was much higher than the resting coronary blood flow reported in normal subjects (approximately 200 mL / min) and was relatively consistent between the proximal and distal segments of the LAD. This study shows that FFR assessment performed with our method is very consistent with the anatomical assessment performed with CCTA. In addition, the study also showed that FFR measurement in distal coronary arteries with a diameter of only 2 mm is feasible as long as appropriate motion correction is applied to TEC. Before motion correction, the AUC in the distal LAD was 4302.5 HU·s, which was much higher than the AUC in the proximal LAD (2512.9 HU·s). The AUC is closely related to the amount of tracer and is meaningless if the distal segment has more tracer than the proximal segment of the same artery. It seems more reasonable that the AUC is slightly lower in the distal LAD compared with the proximal LAD after appropriate motion correction. The slightly lower AUC in the distal LAD is due to the loss of some tracer through the small arterial branches between the proximal and distal LAD.

[0142] Experimental example: Experimental example 3. The results of Experimental Example 3 are similar to those from Figure 8 The use of the mathematical methods described in Examples 1 to 4 is related.

[0143] (a) Patient and scan information. Patient 3 is a 59-year-old male weighing 102 kg. He received 140 μg kg -1 ·min -1 Patients underwent stress CT myocardial perfusion imaging with intravenous infusion of adenosine (vasodilator) at a rate of 1.5 s.l. During the imaging study, 70 mL of iodinated contrast medium was injected at a contrast concentration of 320 mgI / mL (dose: 0.7 mL per kg body weight). Dynamic imaging of 120 mm of the heart was performed in the middle of 25 diastole periods using a 256-line / 160 mm clinical CT scanner at a tube voltage of 100 kV, a tube current of 100 mA, and a gantry rotation speed of 280 ms. The patients held their breath throughout the imaging study. The mean arterial pressure recorded at 3 minutes of adenosine infusion was 124 / 60 mmHg.

[0144] (b) accompanying drawings. Fig.19 a and Fig.19 b shows a contrast-enhanced cardiac image at one axial slice position. The ROIs where the aorta and LAD TEC were measured are shown. The two axial slices are 10 mm apart. Fig.19 c and Fig.19 d shows an axial slice where the proximal and distal RCA TECs were measured. Similarly, Fig.19 e and Fig.19 f shows a slice where the proximal and distal LCx TECs were measured. Fig. 20 a to Fig. 20 c shows the TEC measured from LAD, RCA and LCx, respectively. Aortic TEC is also shown in each figure for comparison. Fig.21 The FFR-CT images of each coronary artery are shown. The dashed circle in each image indicates the approximate location where FFR measurements were made using our dynamic angiography method. Fig. 22 a shows a reformatted view of the LAD curve. Fig. 22 b shows material decomposition of plaque in the LAD using CT value-based segmentation. Fig. 22 c shows a cross-sectional view of the LAD, where the plaque is broken down into Fig. 22 Different substances shown in b. Fig. 22 d and Fig. 22 e shows a reformatted luminal view of the LAD, where the diameters of the segments before, during and after stenosis are marked. It is clear that the lumen in the proximal segment is narrowed by more than 50%.

[0145] (c) Results. The findings from Patient 3 related to blood flow velocity, blood flow pressure, and FFR calculation are summarized in Table 4.

[0146] Table 4. Summary of physiological measurements of LAD (stenotic), RCA (non-stenotic), and LCx (non-stenotic) in patient 3.

[0147]

[0148]

[0149] (i) RCA. CCTA revealed no stenosis in the RCA. Fig.19 c and Fig.19 The proximal and distal segments of the RCA shown in d are 6.0 cm apart. The coronary blood flow in the proximal and distal RCAs was 463.9 mL / min and 509.3 mL / min, respectively. The pressure difference between the two segments was -9.0 mmHg. The FFR derived from our method was 0.93, which is very close to the FFR value estimated by FFR-CT (0.96).

[0150] (ii) LCx. CCTA showed no stenosis in the LCx. Fig.19 e and Fig.19The proximal and distal segments of the LCx shown in f are 5.35 cm apart. The coronary blood flow rates of the proximal and distal LCx segments were 337.0 mL / min and 435.9 mL / min, respectively. The flow pressure difference between the two segments was -19.26 mmHg. The corresponding FFR derived from our method was 0.84, which was almost equal to the FFR value estimated by FFR-CT (0.83).

[0151] (iii) LAD. CCTA revealed long-standing calcification and fatty plaques in the proximal segment of the LAD, which resulted in lumen stenosis of >50% ( Fig. 22 ). Compared with the AUC in the pre-stenotic segment ( Fig. 20 The AUCs in the mid-stenotic and post-stenotic segments were much lower compared with those in the other two non-stenotic arteries ( Fig. 20 b / c) for comparison. The coronary blood flow in the LAD segment before, during, and after stenosis was 396.6 mL / min, 483.1 mL / min, and 600.8 mL / min, respectively. The total pressure loss across the stenosis due to friction and turbulence was -44.5 mmHg (estimated from equations 4, 5, and 10). Considering that the patient's systolic blood pressure during adenosine stress was 124 mmHg (P A ), P B =79.5 mmHg, and therefore FFR equals 0.64. FFR measurements performed with our dynamic angiographic imaging method are inconsistent with the findings of FFR-CT, concluding that the stenotic LAD has a normal FFR value (about 0.91). Both SPECT and CT myocardial perfusion measurements reveal myocardial ischemia. Specifically, CT perfusion measurements showed that the average hyperemic myocardial perfusion in the LAD region was 166.1 ml / min / 100 g, which is much lower than the average hyperemic myocardial perfusion in the non-ischemic myocardium of 21 CAD patients (215.1 ml / min / 100 g, which is the result of our latest single-center study published at the RSNA Scientific Conference in November 2017).

[0152] In addition to blood flow and pressure, other blood flow characteristics are derived. For example, using Figure 8Using the mathematical method described in Example 4 of , the shear stress in the pre-stenotic, mid-stenotic, and post-stenotic segments of the LAD was estimated to be 0.047, 19.68, and 0.33 kPa, respectively. In addition, the areas under the curve (AUC) of the pre-stenotic, mid-stenotic, and post-stenotic segments of the LAD were 2592.79, 2128.44, and 1711.38 HU·s, respectively; the corresponding peak contrast enhancements in the same segments were 254.1, 146.1, and 193.2 HU, respectively; and the corresponding rates of change of AUC in these segments during the washout phase were 20.2, 8.7, and 8.3 HU·s, respectively.

[0153] (d) Interpretation. As shown in a recent systematic review by Cook et al. (2017; JAMA Cardiol. 2(7):803–810), CT-based FFR measurements are very consistent with catheter-based FFR measurements when stenosis is minimal or absent. Patient 3 had a nonstenotic RCA and a nonstenotic LCx, so we could use the FFR-CT assessments in these normal arteries as a reference for comparison with the FFR measurements performed with our method. Our results showed that in these normal (nonstenotic) arteries, our method was very consistent with FFR-CT. However, in the stenotic LAD, there was a clear difference between our method and FFR-CT. Although FFR-CT suggested that the stenosis was not functionally significant (FFR>0.80), the assessment performed with our method indicated that the lesion was indeed obstructive (FFR<0.80). Our findings are consistent with SPECT and CT myocardial perfusion measurements, both of which showed myocardial ischemia. In addition, the AUC in the mid-stenotic and post-stenotic segments was much smaller than that in the pre-stenotic segments, further indicating that there was a large pressure drop across the stenosis. The findings in this study suggest that the dynamic angiographic imaging method presented here is more reliable for the assessment of coronary arteries with intermediate stenosis than FFR-CT.

[0154] Our findings also revealed that stenotic midsegments of the LAD exhibited the greatest shear stress compared to adjacent segments with less stenosis. The ability of our method to assess shear stress opens a new window of opportunity to more accurately assess the risk of plaque rupture (thrombosis), which depends on plaque morphology, composition, and the magnitude of shear forces applied to the plaque. Our results also suggest that other flow features, such as the rate of change of AUC and peak contrast enhancement, can be derived from the same set of images, which may help distinguish between stenotic and nonstenotic arteries.

[0155] Experimental example: Experimental example 4. The results of Experimental Example 4 are similar to those of Figure 8 The mathematical method described in Supplementary Step 1 is used.

[0156] Fig.23 a and Fig.23 b shows two slices of a contrast-enhanced cardiac image, in which the aortic time enhancement curve of patient No. 1 (the same patient as in Experimental Example 1) was measured. The distance between the two slices is approximately 3.5 cm ( Fig.23 c). Slice 1 is just above the ostium of the ascending aorta. The ostia of the left and right coronary arteries are located between slices 1 and 2 (not shown in this reformatted view of the heart). Fig.23 d shows the temporal enhancement curves measured at slices 1 and 2. Fig.23 e provides an enlarged scale to show these curves near their peaks. The areas under the curves (AUCs) at slices 1 and 2 are 4316.75 and 4573.37 HU, respectively. The AUC at slice 1 is 5.6% smaller than the AUC at slice 2. As explained in the mathematical analysis of Supplementary Step 1 above, the results are comparable to the expected values ​​(approximately 5%), indicating that Supplementary Step 1 can be used to estimate the fraction of tracer that enters the coronary system from the aorta.

[0157] Experimental example: Experimental example 5. The results of Experimental Example 5 are similar to those of Figure 8 The use of the mathematical method described in Supplementary Step 2 is relevant.

[0158] Fig.24 a and Fig.24 b shows the left coronary artery of patient No. 2 (the same patient as experimental example 2). Usually, LM only bifurcates into LCx and LAD, but the LM of this patient bifurcates into an intermediate branch (ascending branch) in addition to bifurcating into LCx and LAD. The radius of each vessel and the corresponding maximum contrast enhancement are provided in Table 5. According to equations (20) and (21), the product of the square of the radius of the parent vessel (LM) and the maximum contrast enhancement value (the value in the second to last column in Table 5) should be equal to the sum of the products of each daughter vessel (LCx, LAD and ascending branch). Our findings show that this is the case, with only a 2.85% difference between these values ​​(4890.73 and 5032.29). The slight difference between these values ​​can be attributed to image noise and residual motion in the coronary arteries. The percentage of tracer distributed from the parent vessel (LM) to each daughter vessel (LCx, LAD and ascending branch) is estimated to be 54.2%, 36.5% and 12.2%, respectively. These findings confirm the validity of equations (20) and (21), which provide a reliable method to estimate the mass of tracer in each coronary artery.

[0159] Table 5. Summary of the radius and maximum contrast enhancement and tracer fraction of each left coronary artery in patient 2.

[0160] Coronary arteries Radius (r, cm) <![CDATA[r 2 ]]> Maximum enhancement (HU) <![CDATA[(r 2 )(Max HU)]]> Tracer fraction LM 4.7 22.09 221.4 4890.73 1.000 Proximal LCx 3.7 13.69 193.6 2650.38 0.542 Proximal LAD 3.1 9.61 185.8 1785.54 0.365 ascending branch 1.9 3.61 165.2 596.37 0.122

[0161] Experimental example: Experimental example 6. The results of Experimental Example 6 illustrate the use of time enhancement curves to estimate blood flow without the need for Figure 8 The mathematical methods described in Examples 1 to 4 of the present invention compare non-hyperemic stress with hyperemic stress during scan acquisition and show that additional indices derived from time enhancement curves for functional assessment of blood flow (i.e., in addition to Figure 8 those shown in ).

[0162] Patient Information. Patient 4 is a 78-year-old male with three-vessel coronary artery disease (CAD). Each coronary artery has a different physiology when imaged. This study was used to demonstrate the benefits of DAI in:

[0163] 1. Functional assessment of CAD in the presence of blooming artifacts caused by calcified plaques and metallic stents in the coronary artery lumen;

[0164] 2. Functional assessment of CAD in the presence of multivessel disease;

[0165] 3. In addition to coronary blood flow, shear stress, and fractional flow reserve (FFR), more than one index can be derived from the coronary time enhancement curve that can be useful for the functional assessment of coronary artery stenosis. These indices include the peak enhancement (PE), area under the curve (AUC), upslope and downslope, slope, and kurtosis of the time enhancement curve;

[0166] 4. The indices described in (3) measured at rest may be sufficient for functional CAD assessment, which means that patients may not need to use drugs to obtain hyperemic stress.

[0167] Fig.25 The right coronary artery (RCA) is shown with two calcified plaques close to each other in the proximal segment (white arrows in (a) and (b)). Calcium on each side of the lumen affects the measurement of the lumen diameter, which is information required for current FFR-CT methods based on computational fluid dynamics. The dashed light gray arrows and solid dark gray arrows in (a) and (b) show the locations where the pre-plaque (upstream) and post-plaque (downstream) time enhancement curves are sampled. In the graphs shown in (c) and (d), the circles represent the enhancements measured at different time points in the pre-plaque position at rest and during maximum vasodilation stress, respectively. The dashed light gray curves in these graphs represent the corresponding fitted time enhancement curves. Similarly, the squares in (c) and (d) are the enhancements measured at different time points in the post-plaque position at rest and during stress, respectively. In these graphs, the corresponding fitted time enhancement curves are shown as solid dark gray curves.

[0168] Our results show that under both resting and stress conditions, the time enhancement curves upstream and downstream of the calcified plaque are almost identical to each other. This is evident by the indifferent PE (peak enhancement) and AUC (area under the curve) between the two curves in each case. In addition, the AUC before and after the plaque under stress is significantly reduced compared to resting. AUC is inversely proportional to coronary blood flow. This means that the coronary blood flow in the RCA increases significantly from the baseline (resting) under stress at the positions before and after the plaque, and the amplitude of the increase in blood flow is consistent between the positions before and after the plaque. Therefore, this finding indicates that the plaque is not important functionally.

[0169] Fig.26 The obtuse marginal (OM) branch of the left circumflex coronary (LCx) artery shown in has been stented in the proximal segment. The time enhancement curves measured upstream (dashed light gray arrows in (a) to (c)) and downstream (solid dark gray arrows in (a) to (c)) of the stent are shown in the graphs in (d) and (e). The reformatted view of the OM artery (c) shows that visualization of the lumen is significantly affected by blooming artifacts, with the middle portion of the stent appearing to be completely blocked. However, the time enhancement curve acquired after the stent (downstream) at rest (dark gray graph with square marks in (d)) shows that the stented lumen is narrowed but not completely blocked because contrast agent passes through at this sampling site. At rest, the AUC after the stent is much smaller than the AUC before the stent, indicating that coronary blood flow after the stent is faster than before the stent, which is due to the narrower stented lumen, as described by the Bernoulli equation.

[0170] The pre-stent AUC under stress (dashed light gray graph with circle markers in (e)) was much smaller than the pre-stent AUC at rest (dashed light gray graph in (d)), whereas the post-stent AUC under stress (solid dark gray graph with square markers in (e)) was minimally reduced from the AUC at rest (solid dark gray graph in (d)). This finding suggests that there was a large increase in coronary blood flow in the segment before the stent was stressed due to maximal vasodilation, but the increase in blood flow after stenting was small due to the absence or minimal vasodilation. Therefore, in-stent stenosis may be functionally important.

[0171] Fig. 27The left anterior descending artery (LAD) is shown with multiple lesions. The proximal segment has complex calcified and non-calcified plaques (white arrows in (a) to (c); the middle segment has been stented). The dashed light gray and solid dark gray arrows in (a) to (c) indicate the locations where the pre-plaque and post-plaque time enhancement curves were measured. The pre-plaque (circle markers) and post-plaque (square markers) time enhancement curves measured at rest and under stress are shown in (d) and (e), respectively.

[0172] The results showed that the AUC of the post-plaque curve decreased relative to the pre-plaque curve under both resting and stressed conditions. Fig.25 ), this plaque was functionally insignificant compared to the stenotic stent in the proximal LAD, with plaques in the proximal LAD causing a greater degree of lumen stenosis, as reflected by a larger decrease in AUC across the plaque at rest. However, by comparing the LAD plaque post-curves between rest and stressed conditions, we demonstrated a significant increase in coronary blood flow under stress, suggesting that plaques in the proximal LAD may be functionally less important than stenotic stents in LCx ( Fig.26 ) is not as important as the figure, which shows the minimal increase in blood flow under stress in the segment below the stent.

[0173] The indices of blood flow, flow pressure, FFR, and shear stress have been exemplified in Experimental Examples 1 to 3. Other indices derived from the time enhancement curve can be used for functional evaluation of coronary artery stenosis. Fig.25 and Fig.26 The time enhancement curves shown in can be used to illustrate other indices. We first review the time enhancement curves in RCA obtained before and after plaque ( Fig.25 ). As mentioned above, the two curves are very similar to each other, indicating that the lumen narrowing between the two sites is minimal. The appearance of the time enhancement curve can be quantitatively described using the following examples of other indicators: area under the curve (AUC), peak enhancement (PE), upslope, downslope, slope, kurtosis. The slope describes the asymmetry of the curve and its value ranges from -1 to +1. A zero slope means that the curve is completely symmetrical on both sides (upslope side compared to downslope side). A negative slope means that the tail of the curve on the left (upslope) side is longer than the tail on the right (downslope) side, while a positive slope means that the tail of the curve on the right (downslope) side is longer than the tail on the left (upslope) side. In contrast, kurtosis describes the sharpness of the curve. The normal value of kurtosis is 3. If the kurtosis is less than 3, the curve is flatter than the normal curve, while a kurtosis greater than 3 means that the curve has a higher peak than the normal curve. Table 6 summarizes the indicators of the pre-plaque and post-plaque curves of RCA at rest. The difference of each index between the pre-plaque curve and the post-plaque curve is given by the subtraction of the two indexes (post-previous) and the ratio of the two indexes (post-previous).

[0174] Table 6

[0175] Rest AUC (HU·s) PE(HU) Uphill (HU / s) Downhill (HU / s) slope Kurtosis RCA preplaque 4047.51 355.49 52.74 -36.57 0.595 -1.211 RCA plaque 3982.01 361.00 49.93 -36.01 0.634 -1.163 Difference -65.5 5.51 -2.81 0.558 0.039 0.048 ratio 0.984 1.015 0.947 0.985 1.066 0.960

[0176] The same metrics used for the RCA pre-plaque and post-plaque curves under stress are summarized in Table 7:

[0177] Table 7

[0178] Stress AUC (HU·s) PE(HU) Uphill (HU / s) Downhill (HU / s) slope Kurtosis RCA preplaque 2452.44 224.03 17.33 -18.23 0.660 -1.129 RCA plaque 2369.71 214.68 13.98 -16.84 0.653 -1.138 Difference -82.73 -9.35 -3.35 1.384 -0.007 -0.009 ratio 0.966 0.958 0.807 0.924 0.989 1.008

[0179] The same metrics for pre- and post-stent curves in the OM branch of the LCx artery at rest are shown in Table 8:

[0180] Table 8

[0181] Rest AUC (HU·s) PE(HU) Uphill (HU / s) Downhill (HU / s) slope Kurtosis Before LCx stent 3524.68 303.33 44.83 -30.89 0.571 -1.238 After LCx stenting 999.25 107.78 14.96 -13.49 0.903 -0.736 Difference -2525.43 -195.55 -29.87 17.41 0.332 0.502 ratio 0.284 0.353 0.334 0.437 1.581 0.595

[0182] The same metrics for pre- and post-stent curves in the OM branch of the LCx artery under stress are provided in Table 9:

[0183] Table 9

[0184] Stress AUC (HU·s) PE(HU) Uphill (HU / s) Downhill (HU / s) slope Kurtosis Before LCx stent 1311.12 87.57 4.886 -6.247 0.171 -1.452 After LCx stenting 1001.44 75.10 9.840 -5.241 0.308 -1.427 Difference -309.68 -12.47 4.954 1.006 0.137 0.025 ratio 0.764 0.868 2.014 0.839 1.801 0.983

[0185] It is clear that the RCA pre-plaque and post-plaque curves are not significantly different from each other, as reflected by their comparable AUC, PE, slope, slope, and kurtosis under both resting and stressed conditions (the ratio associated with each index is close to unity under both resting and stressed conditions). In addition, the RCA curve under stress has a lower AUC / PE / slope but similar slope / kurtosis compared to the RCA curve at rest, indicating that the changes in the coronary artery time enhancement curves at both ends of the plaque in the proximal RCA under stress are mainly due to the higher flow during maximum vascular dilation, because the curves are not significantly distorted due to complex lumen narrowing. In contrast, the LCx stent pre- and post-stent curves are very different from each other, as reflected by the larger differences in the indicators, and the corresponding ratios show a greater difference from unity. The results show that the coronary artery time enhancement curve is significantly distorted by lumen narrowing within the stent.

[0186] In conclusion, Fig.25 (RCA plaque) and Fig.26 The example shown in (LCx stent) shows that indices other than coronary blood flow, FFR and shear stress can be derived from the coronary time enhancement curve. These additional indices obtained under resting physiological conditions and stressed physiological conditions can be used alone or in combination to perform functional assessment of coronary artery lesions.

[0187] Experimental example: Experimental example 7.The results of Experimental Example 7 illustrate the adaptability of the DAI method and system to imaging modalities other than CT. More specifically, Example 7 illustrates the DAI method and system incorporating invasive coronary angiography as an imaging technique.

[0188] One difference of invasive coronary angiography compared to contrast-enhanced CT is that a large dose of X-ray dye (iodinated contrast) is injected directly into the left or right coronary artery at the ostium via a catheter (selective angiography) rather than intravenously. The passage of the contrast solution through the artery results in a decrease in signal intensity in the vessel (the X-ray dye appears dark, as opposed to bright in CT angiography or CT perfusion source images). Fig.28 In (a) to (f), the initial passage of contrast agent in the LAD artery is shown. In order to obtain a coronary artery time enhancement curve similar to other previous examples, we first measure the pixel intensity in the motion-corrected coronary artery at different image frames, which cover the time period from before the contrast agent washout to after the contrast agent washout. The measured pixel intensity values ​​at the sampling sites represented by the white arrows in (a) to (f) are shown in (g). When there is no contrast agent in the artery, we then calculate the absolute change in pixel intensity relative to the first time point, and convert the image frame number to time using the image acquisition rate applied in coronary angiography. In this study, images were acquired at a speed of 30 frames per second. We can now convert the curve graph in (g) to the curve graph in (h), where the y-axis is the absolute change in pixel intensity (contrast enhancement) and the x-axis is time. The dotted line in (h) represents the fitting curve of the measured data.

[0189] As mentioned before, we also need to know the total mass of the tracer injected into the artery. In this study, 10 mL of contrast agent with a concentration of 270 mgI / mL was injected at the mouth, and about 3 mL of contrast agent entered the ascending aorta and not the left coronary artery (i.e., about 7 mL of contrast agent in the left coronary artery). We also need to know the conversion factor between the unit increase in pixel intensity and the concentration of the contrast agent in the coronary angiography, which can be determined from the human model experiment. With all the information, we can derive the coronary blood flow, FFR, and other indicators shown in the previous experimental examples.

[0190] Fig.29 Shown with Fig.28Another example obtained from the same pig is shown in to illustrate that the proposed method can be applied to any artery of interest in selective coronary angiography. In this study, contrast agent was injected directly into the right coronary artery (RCA) at the ostium. The images in (a) to (f) show the first circulation of contrast agent in the RCA over a short time period. The data in (g) show the pixel intensity measured from the motion-corrected RCA at the sampling sites indicated by the white arrows in (a) to (f), and the corresponding coronary artery time enhancement curve is shown as a dashed line in (h).

[0191] Experimental example: Experimental example 8. The results of Experimental Example 8 illustrate the adaptability of the DAI method and system to imaging modalities other than CT. More specifically, Example 8 shows the DAI method and system incorporating MRI as an imaging technique. Gadolinium-based T1-weighted MR myocardial perfusion imaging.

[0192] Fig.30 Shows from Fig.28 and Fig.29 Images obtained from an MRI study of the same pig. Fig.30 The images shown in (a) and (b) were acquired in a supine scanning position similar to that of clinical CT and MRI studies. Together, these images illustrate that in a transaxial view, coronary arteries such as the RCA and LAD can be seen in different tomographic slice positions. The ascending aorta can also be seen in each slice for comparison.

[0193] Fig.30 The images shown in (c) to (n) are T1-weighted images acquired at the same slice positions as in (a) after a bolus injection of a gadolinium-based contrast agent. It is clear that the circulation of contrast agent in the pulmonary vasculature can be seen at the beginning, followed by the circulation of contrast agent in the ascending aorta and coronary arteries (RCA). The washout of contrast agent can be seen at the end of the image series. To avoid signal saturation, a low dose of contrast agent (approximately 1 mmole per 20 kg body weight) was used with an injection rate of 2.5 mL / s, followed by a saline flush. Imaging was ECG triggered and one frame was acquired for each heartbeat. Because the arrival of contrast agent changes the signal intensity of voxels within the arteries, we can obtain coronary artery time enhancement curves in a manner similar to CT and invasive coronary angiography, and provide functional assessment as in the previous experimental examples.

[0194] Several illustrative variations of a method or system for dynamic angiographic imaging (DAI) have been described above. Additional variations and modifications are described below. In addition, a guiding relationship for configuring the variations and modifications is also described below. Additional variations and modifications are contemplated and will be recognized by those skilled in the art. It should be understood that the guiding relationship and illustrative variations or modifications are provided to enhance the understanding of those skilled in the art and are not intended to be limiting statements.

[0195] For example, Figure 2 The DAI method 20 shown is illustrative only and should not be considered limiting of the DAI method as the DAI method may be replaced or removed as desired for a particular embodiment. Figure 2 One or more steps shown. For example, in certain embodiments, the CT scan of the subject may be geographically or temporally offset from the image reconstruction. Figure 7 An example of a modified DAI method 20a is shown in which both projection data from a CT scan and image reconstruction occur at a prior stage and the reconstructed images are stored for analysis at a later date or for analysis by a third party. The modified DAI method 20a begins by acquiring 60a stored image data. Contrast agent signal data may then be extracted 74a from the stored image data, optionally without explicitly identifying the target vessel in the image data. A time enhancement curve is generated 76 based on the contrast agent signal data, the time enhancement curve having an upslope drawn from data points obtained during an increasing phase of the contrast agent signal data, and a downslope drawn from data points obtained during a decreasing phase of the contrast agent signal data. The contrast agent signal data may then be analyzed based on the contrast agent signal data. Figure 6 The same method steps as shown are used to determine the FFR value.

[0196] As another example, the DAI method and system are not limited to computed tomography (CT) scanning, and can be easily adapted to other imaging modalities with sufficient spatial resolution to image blood vessels, including MRI and other X-ray imaging techniques (i.e., X-ray imaging techniques other than CT imaging), including, for example, fluoroscopy. X-ray-based scanning is a form of medical imaging that includes the transmission of high-frequency electromagnetic signals that attenuate as they pass through the subject's body, with the remaining signals captured by a detector for subsequent analysis. An alternative to X-ray-based scanning is magnetic resonance imaging (MRI), which has recognized medical imaging applications, including, for example, imaging for diagnosing diseases in soft tissues such as the brain, lungs, liver, muscles, and heart. MRI scanning involves the application of a magnetic field to a patient and the transmission of radio frequency pulses. The resonant energy is emitted by the patient and picked up by a receiver / detector that captures the scan data for subsequent analysis. To improve image clarity, both X-ray scanning and MRI scanning involve the oral or intravenous administration of contrast agents to the patient. Contrast agents used in X-ray imaging techniques include, for example, iodine-based contrast agents. Contrast agents used in MRI imaging techniques include, for example, gadolinium-based contrast agents. Scan data acquired from an X-ray based scanner device / system is often interchangeably referred to as scan data or projection data, whereas scan data acquired from an MRI scanner device / system is typically referred to as scan data. Thus, the term scan data should be understood to encompass the term projection data.

[0197] Contrast agents (also called tracers) for use with various imaging modalities are well established in the current literature and continue to be an active area of ​​development of new alternatives. The DAI methods and systems can accommodate any suitable combination of contrast agents and imaging modalities, provided that the imaging modality provides sufficient spatial resolution to image the vessel of interest or a portion of a vessel of interest.

[0198] The elapsed time of the imaging scan process (equal to the duration of the scan data acquisition) can be changed as needed, provided that the imaging scan captures at least a portion of both the increase phase and the decrease phase of the contrast agent at the sampling site in order to obtain sufficient data to estimate the shape of the time enhancement curve. Typically, in order to capture both the increase phase and the decrease phase, an imaging scan of more than 5 seconds is required. In some examples, the imaging scan can be configured to capture scan data for more than 6 seconds, more than 7 seconds, more than 8 seconds, more than 9 seconds, or more than 10 seconds. Although not limited by the upper limit time, nor by the delivery time of the contrast agent, many times the imaging scan will not extend significantly beyond the expected delivery time of the contrast agent at the sampling site.

[0199] The number of images (also referred to as frames or separate scans) analyzed to generate the time enhancement curve can be changed as desired, provided that the number of images cumulatively captures at least a portion of both the increase phase and the decrease phase of the contrast agent at the sampling site in order to obtain sufficient data to estimate the shape of the time enhancement curve. Typically, in order to capture both the increase phase and the decrease phase, an imaging scan of more than 5 images is required. In some examples, the imaging scan can be configured to capture scan data for more than 6 images, more than 8 images, more than 10 images, more than 12 images, more than 14 images, more than 16 images, more than 18 images, or more than 20 images. In addition, it is observed that imaging scans configured to capture at least 10 images are beneficial to peak determination and consistency of curve shape; signal intensity values ​​do not need to be extracted from all of the at least 10 images, but at least 10 images generally provide a set of images large enough to select a subset of appropriate time distribution images (usually 5 or more images) to obtain consistency in estimating the shape of the curve.

[0200] The DAI method and system are considered dynamic because multiple images are analyzed, unlike static techniques that evaluate a single image. Most commercially available CT angiography techniques are static. In addition, the minimally dynamic commercially available CT angiography techniques (evaluating 2 to 3 images) do not recognize or take into account the benefits of acquiring scan data from both the ramp-up and ramp-down phases of contrast agent delivery or generating a time enhancement curve with an upslope, peak, and downslope.

[0201] The plurality of images (e.g., at least 5 images) used to generate the time enhancement curve are considered as a plurality of corresponding images, wherein the corresponding relationship of the images refers to the time order sequence of the plurality of images located at the same sampling site or slice or a group of adjacent sampling sites or slices (e.g., as described above for Figure 8, adjacent sampling sites may be considered in motion correction). Therefore, the correspondence of the images is spatially limited to a single sampling site or a set of adjacent sampling sites, and the correspondence of the images does not include sampling sites that are spatially separated into upstream and downstream of a source of abnormal blood flow. For example, when determining a blood flow characteristic includes comparing corresponding values ​​calculated from a first time enhancement curve and a second time enhancement curve, a first time enhancement curve may be generated from a first plurality (or a set) of corresponding images from a first sampling site located upstream of a suspected source of abnormal blood flow, and a second time enhancement curve may be generated from a second plurality (or a set) of corresponding images from a second sampling site located downstream of a suspected source of abnormal blood flow. In this example, the first set of corresponding images will not be mixed with the second set of corresponding images because the first sampling site and the second sampling site are spatially separated by an intervening source of abnormal blood flow. However, as an example of alignment, such as may occur for motion correction processing, when a first sampling site and a second sampling site (slice) are adjacently docked or nearly adjacently docked, a first set of corresponding images from the first sampling site can be blended with a second set of corresponding images from the second sampling site in a time-specific manner (so as to maintain a temporal sequential sequence in the resulting blended set of corresponding images) to minimize blood flow differences between the first sampling site and the second sampling site.

[0202] Each group or multiple corresponding images are time-ordered or time-resolved to generate a time enhancement curve. The time enhancement curve has an upslope, a peak, and a downslope. Time ordering is required to generate the time enhancement curve so that the upslope of the time enhancement curve is interpolated from time-specific contrast agent signal data points acquired during the increasing phase of contrast agent delivery, and the downslope of the time enhancement curve is interpolated from time-specific contrast agent signal data points acquired during the decreasing phase of contrast agent delivery. Therefore, the acquisition of scan data and the reconstruction of image data are performed with reference to a time ordering scheme so that each group of corresponding images obtained from the image data can be arranged in a time-ordered order. The time ordering scheme can be any convenient scheme that includes a time stamp having a real-time identifier, a relative time identifier (such as the time elapsed after a bolus injection), or any custom time identifier that can be used to identify each image and the absolute or relative time of the time-resolved sequence of a group of corresponding images. In formulating the time ordering scheme, an established protocol for the time interval between the administration of contrast agent and the acquisition of images can be used. Additionally, established timing techniques, such as bolus tracking, may be employed to optimize the timing of scan acquisition and the temporal sequencing of image data.

[0203] A time enhancement curve is a graph of contrast agent signal intensity versus time that is derived from scan data of contrast agent delivery at a single sampling site or a set of adjacent sampling sites (e.g., for motion correction). A time enhancement curve may also be referred to as a time density curve, a signal intensity time curve, a time-dependent signal intensity, a time intensity curve, and other variations. The term enhancement within a time enhancement curve refers to an increase in contrast agent signal intensity measured relative to a baseline or reference value (such as the signal intensity measured at a minimum level of contrast agent or measured at a residual level of contrast agent or measured in the absence of contrast agent). Qualitative terms describing contrast agent delivery, such as before entry, entry, washout, ramp-up phase, ramp-down phase, washout, washout, and after washout, refer to a bolus injection event or, more generally, a contrast agent administration event, such that each of these terms describes a portion of contrast agent delivery (other than before entry) that occurs after the associated injection or administration event. The term before entry may correspond to a time range that may begin earlier than the injection or administration event.

[0204] In many examples, the DAI method and system include the generation of at least one time enhancement curve. However, in certain examples where it is not necessary to evaluate the time enhancement curve (e.g., blood flow characteristics based on peak enhancement values), it may not be necessary to generate a time enhancement curve, and therefore in these examples, the time-resolved sorting of a set of corresponding images also becomes optional; more specifically, a set of corresponding images can be queried to identify and select images with peak signal intensity and extract peak enhancement values ​​without establishing a time enhancement curve. The risk of extracting peak enhancement values ​​without a time enhancement curve is that the selected image of peak signal intensity may be an outlier that may not be obvious without comparison with the time enhancement curve; however, this risk may be acceptable for general screening assessments, such as performing an assessment of multiple sampling sites of multiple blood vessels in an organ in data acquired from a single scanning session used as an active screening tool to identify blood flow abnormalities. Regardless of the optionality of the generation of time enhancement curves and the optionality of time-resolved sorting, the DAI method and system require image data that includes multiple corresponding images that capture at least a portion of the increasing phase and the decreasing phase of contrast agent delivery through the blood vessel of interest.

[0205] The DAI methods and systems described herein allow for the determination of blood flow characteristics. A blood flow characteristic can be any indicator of blood flow in an area of ​​interest within a subject. Blood flow characteristics include, for example, flow rate, flow velocity, and flow pressure. Rate, velocity, and pressure are indicators of blood flow. FFR is another indicator. Shear stress is another indicator. The area under the curve, the rate of change of the area under the curve, the peak value (maximum value) of the curve, and blood volume can be considered other examples of blood flow characteristics. Examples of calculations for determining flow rate, flow velocity, flow pressure, FFR, and shear stress are provided in the Mathematical Analysis section. From Fig. 20 Clearly seen is the benefit of determining the area under the curve (AUC), the rate of change of area under the curve, and the peak of the curve. Fig. 20 It is also shown that the time enhancement curve itself indicates blood flow at the sampling site, and therefore, the time enhancement curve itself can be considered a blood flow feature. Other examples and comparisons of other indicators of area under the curve (AUC), peak enhancement (PE), upslope, downslope, slope and kurtosis derived from the time enhancement curve are shown in Tables 6 to 9.

[0206] The assessment of blood flow and the determination of blood flow characteristics can provide diagnostic results. For example, determining the time enhancement curves at the first and second sampling sites will produce a first time enhancement curve and a second time enhancement curve; and the estimation of blood flow characteristics includes a determination, which includes calculating corresponding values ​​from the first time enhancement curve and the second time enhancement curve. The blood flow characteristic value itself can provide a diagnostic result. In another example, the corresponding values ​​calculated from the first time enhancement curve and the second time enhancement curve are compared, and the difference in the corresponding values ​​exceeding a predetermined threshold indicates a diagnostic result. The thresholds and corresponding diagnostic results can be adopted from relevant literature and medical guidelines. For example, based on the latest literature on FFR diagnostic analysis, approximately 0.8 is considered normal, while below 0.8 indicates that stenosis may have functional significance. In addition, by repeatedly using the DAI method and system, various correlations between indicators, thresholds, and diagnostic results can be developed.

[0207] A region of interest (ROI) is an area on a digital image that circumscribes or contains a desired anatomical location (e.g., a vessel of interest or a portion of a vessel of interest). An image processing system allows data to be extracted from an ROI on an image, including, for example, an average parameter value calculated for all pixels within the ROI. A sampling site is the location of one or more imaging slices that are selected to evaluate a desired anatomical location, such as a vessel of interest. When a sampling site is at or near the ROI, the ROI may be used interchangeably with the sampling site. In some examples, analysis of a time enhancement curve from a single sampling site may be sufficient to determine a blood flow characteristic or index. In other examples, multiple sampling sites or multiple imaging slices may be analyzed to obtain multiple corresponding image groups and generate multiple corresponding time enhancement curves, and any number of the multiple corresponding time enhancement curves may be compared to determine a blood flow characteristic or blood flow index. A conventional scanner may capture 3D image data of all or part of a vessel of interest, and may even capture 3D image data of all or part of multiple vessels of interest. In addition, the scan can be subdivided into multiple slices as needed, and it is therefore feasible and convenient to interrogate multiple sites or slices at the ROI, near the ROI, upstream of the ROI, downstream of any ROI, or any combination thereof. In a multi-slice or multi-site imaging modality, each scan can extract simultaneous tomographic slices or sampling sites. Therefore, the DAI method does not have to be limited to analysis of one or two time enhancement curves of a scan for contrast agent delivery (entry to clearance) at the vessel of interest, and a single scanning process with a single bolus injection of contrast agent can support multiple slices or sampling sites divided from the scan data as needed.

[0208] The vessel of interest can be any vessel that can be imaged by contrast-enhanced imaging techniques. The vessel of interest will typically have a diameter of at least about 0.1 mm, such as a diameter greater than 0.2 mm or a diameter greater than 0.3 mm. The vessel of interest or a designated portion of the vessel of interest can be identified and imaged for contrast-enhanced dynamic angiography to determine the diagnosis of vascular disease or to determine susceptibility to vascular disease. The vessel of interest can be in any anatomical region or any organ (e.g., brain, lung, heart, liver, kidney, etc.) in an animal body (e.g., a human body).

[0209] The DAI method is not limited to scan data acquired when the subject is in a hyperemic state (also known as hyperemic stress or vasodilatory stress) and time enhancement curves generated from scan data acquired when the subject is in a non-hyperemic state (also known as a resting state) can produce useful results. Examples of useful time enhancement curves generated from scan data acquired from a subject in a resting state are Figure 25 to Figure 27Inducing a hyperemic state is a well-known medical protocol in blood flow assessment and typically involves the administration of vasodilators, such as adenosine, sodium nitroprusside, dipyridamole, regadenoson, or nitroglycerin. The mode of administration of vasodilators may vary depending on the imaging protocol and may include intravenous or intracoronary injection.

[0210] In order to determine whether vascular disease is present at a vessel of interest, blood flow characteristics are analyzed based on at least one time enhancement curve, including, for example, a single time enhancement curve generated from a scan of a single sampling site, or as another example, multiple time enhancement curves generated from corresponding multiple sampling sites, respectively. In the case of stenosis, comparing the two sampling sites is beneficial in comparing the blood flow characteristics determined at the sampling site upstream of the stenosis with the blood flow characteristics determined at the sampling site downstream of the stenosis. For example, by definition, FFR (see Equation 9) can be considered as a flow pressure ratio, where the flow pressure determined downstream of the stenosis is the numerator and the flow pressure determined upstream of the stenosis is the denominator. More generally, when a vessel of interest is identified, multiple sampling sites can be specified at or near the vessel of interest; a time enhancement curve can be generated for each of the multiple sampling sites; a desired blood flow characteristic can be obtained based on the corresponding time enhancement curve determined for each of the multiple sampling sites; and the determined blood flow characteristics of each of the multiple sampling sites can be compared to determine vascular disease. In a simplified but effective form, Fig. 20 a shows that comparison of time enhancement curves generated at multiple sampling sites at or near a vessel of interest is effective in determining the presence or absence of vascular disease. According to specific embodiments, determining blood flow characteristics at one or more sampling sites or determining the presence or absence of vascular disease based on comparison of blood flow characteristics at multiple sampling sites can provide a diagnostic result.

[0211] The vascular disease (also referred to as vascular disease) assessed by the methods or systems described herein can be any unhealthy blood flow abnormality, such as functionally important blood flow restriction or blood flow obstruction in cardiac or non-cardiac blood that may impair the health of the subject, including, for example, unhealthy blood flow abnormality symptoms of atherosclerosis (e.g., plaque formation), carotid artery disease, peripheral artery disease including renal artery disease, aneurysms, Raynaud's phenomenon (Raynaud's disease or Raynaud's syndrome), Buerger's disease, peripheral venous disease and varicose veins, thrombosis and embolism (e.g., blood clotting in veins), blood clotting disorders, ischemia, angina, heart attack, stroke, and lymphedema.

[0212] The DAI method and system can be used, for example, to evaluate suspected blood flow disorders by determining blood flow characteristics at a vessel of interest that was identified in a previous medical examination as a possible source of unhealthy blood flow abnormalities. In addition, due in part to the reduced time to capture scan data of multiple vessels and process the scan data, the DAI method and system can be used to proactively evaluate blood flow in a particular vessel or a particular group of vessels (e.g., coronary blood flow evaluation) for the first time, and can be implemented as a screening tool as an initial indication for identifying the source of an unhealthy blood flow abnormality (such as a functionally significant stenosis).

[0213] The DAI method does not require the scanned subject or patient to hold his breath during the scan. In some examples, holding the breath is an option. In other examples, motion correction or motion compensation processing of the image data can be used for scan data acquired without holding the subject or patient's breath.

[0214] The embodiments disclosed herein or portions thereof may be implemented by programming one or more computer systems or devices with computer executable instructions embodied in a non-transitory computer readable medium. When executed by a processor, these instructions operate to cause these computer systems and devices to perform one or more functions specific to the embodiments disclosed herein. The programming techniques, computer languages, devices, and computer readable media required to achieve this purpose are known in the art.

[0215] In one example, a non-transitory computer-readable medium embodying a computer program for dynamic angiographic imaging may include: computer program code for obtaining image data, the image data including a plurality of corresponding images capturing at least a portion of both an increasing phase and a decreasing phase of a contrast agent in a blood vessel of interest; computer program code for generating at least one time enhancement curve of the contrast agent based on the image data, the time enhancement curve having an upslope and a downslope; and computer program code for determining blood flow characteristics in the blood vessel of interest based on the time enhancement curve. In another related example, the image data includes at least one image capturing the blood vessel of interest before the contrast agent enters. In yet another related example, the computer-readable medium further includes computer program code for determining a reference value based on at least one image capturing the blood vessel of interest before the contrast agent enters, and normalizing the time enhancement curve based on the reference value. In yet another related example, the computer-readable medium further includes computer program code for acquiring scan data of the blood vessel of interest from an X-ray-based scan or an MRI scan, and reconstructing image data based on the scan data.

[0216] Computer readable media is a data storage device that can store data, which can be subsequently read by a computer system. Examples of computer readable media include read-only memory, random access memory, CD-ROM, magnetic tape, optical data storage devices, etc. Computer readable media can be geographically located or distributed on network-connected computer systems so that computer readable code is stored and executed in a distributed manner.

[0217] Computer embodiments of the system or method typically include a memory, an interface, and a processor. The types and arrangements of the memory, interface, and processor may vary depending on the embodiment. For example, the interface may include a software interface that communicates with an end-user computing device via an Internet connection. The interface may also include a physical electronic device configured to receive a request or query from a device that sends digital and / or analog information. In other examples, the interface may include a physical electronic device configured to receive signals and / or data related to the DAI method and system, such as from an imaging scanner or image processing device.

[0218] Depending on the specific embodiment, any suitable processor type may be used, including, for example, a microprocessor, a programmable logic controller, or a field programmable logic array. In addition, any conventional computer architecture may be used for computer embodiments of the system or method, including, for example, memory, mass storage devices, processors (CPUs), read-only memories (ROMs), and random access memories (RAMs) that are typically connected to a system bus of a data processing device. The memory may be implemented as a ROM, a RAM, a combination thereof, or simply as a general-purpose memory unit. Software modules in the form of routines and / or subroutines for executing features of the system or method may be stored in the memory and then retrieved and processed via the processor to perform a specific task or function. Similarly, one or more method steps may be encoded as program components, stored in the memory as executable instructions, and then retrieved and processed via the processor. User input devices such as keyboards, mice, or other pointing devices may be connected to a PCI (peripheral component interconnect) bus. If desired, the software may provide an environment representing programs, files, options, etc., by means of graphical display icons, menus, and dialog boxes on a computer monitor screen. For example, any number of blood flow images and blood flow features may be displayed, including, for example, time enhancement curves.

[0219] Computer embodiments of the system or method can accommodate any type of end-user computing device, including computing devices that communicate over a network connection. The computing device can display graphical interface elements for performing various functions of the system or method, including, for example, a display showing blood flow characteristics determined for a vessel of interest. For example, the computing device can be a server, a desktop computer, a laptop computer, a notebook computer, a tablet computer, a personal digital assistant (PDA), a PDA phone, or a smart phone, etc. The computing device can be implemented using any suitable combination of hardware and / or software configured for wired and / or wireless communications. Communications can be performed over a network, for example, where remote control of the system is desired.

[0220] If a network connection is required, the system or method can adapt to any type of network. The network can be a single network or a combination of multiple networks. For example, the network can include the Internet and / or one or more intranets, landline networks, wireless networks, and / or other appropriate types of communication networks. In another example, the network can include a wireless telecommunications network (e.g., a cellular telephone network) suitable for communicating with other communication networks (such as the Internet). For example, the network can include a computer network that utilizes the TCP / IP protocol (including protocols based on the TCP / IP protocol, such as HTTP, HTTPS, or FTP).

[0221] The embodiments described herein are intended for illustrative purposes without any intended loss of generality. Additional variations, modifications, and combinations thereof are contemplated and will be recognized by those skilled in the art. Therefore, the foregoing detailed description is not intended to limit the scope, applicability, or configuration of the claimed subject matter.

Claims

1. A computer-implemented method for dynamic angiographic imaging, include: obtaining CT or MRI image data comprising a plurality of corresponding images that capture at least a portion of both a ramp-up phase and a ramp-down phase of contrast agent in a vessel of interest; generating at least one time enhancement curve of the contrast agent based on the CT or MRI image data, the time enhancement curve having an upslope and a downslope; and A blood flow characteristic in the vessel of interest is determined based on a ratio of the mass of the contrast agent in the vessel of interest to the area under the time enhancement curve.

2. The method according to claim 1, in, The CT or MRI image data includes at least one image capturing the blood vessel of interest prior to entry of the contrast agent, and The method further includes determining a reference value based on the at least one image captured of the blood vessel of interest before entry of the contrast agent, and normalizing the time enhancement curve based on the reference value.

3. The method according to claim 1, in, The area under the time enhancement curve is converted into the concentration of the contrast agent in the vessel of interest.

4. The method according to claim 2, in, The area under the time enhancement curve is converted into the concentration of the contrast agent in the vessel of interest.

5. The method of claim 1 , further comprising acquiring scan data of the blood vessel of interest from an X-ray-based CT scan or an MRI scan by scanning a subject with a contrast agent to acquire scan data, the scan data capturing at least a portion of both an increasing phase and a decreasing phase of the contrast agent in the blood vessel of interest, and reconstructing the CT or MRI image data based on the scan data, and in, The plurality of corresponding images is greater than 5 images.

6. The method according to any one of claims 1 to 5, in, Determining the blood flow characteristic includes determining a fractional flow reserve (FFR) value for a hyperemic state or a resting state based on the ratio and using the Bernoulli equation expressed as follows:

7. The method according to claim 6, in, The FFR is determined at multiple sites within the vessel of interest.

8. The method according to any one of claims 1 to 5, in, Determining the blood flow characteristic includes determining a shear stress of the blood vessel of interest based on the ratio, a radius of the blood vessel of interest, and blood viscosity.

9. The method according to any one of claims 1 to 5, in, The at least one time enhancement curve comprises a first time enhancement curve and a second time enhancement curve; as well as Determining the blood flow characteristic includes comparing corresponding values ​​calculated from the first time enhancement curve and the second time enhancement curve.

10. The method according to claim 9, in, The first time enhancement curve is generated from image data from a first sampling site located upstream of a suspected source of blood flow abnormality, and the second time enhancement curve is generated from image data from a second sampling site located downstream of the suspected source of the blood flow abnormality.

11. The method according to claim 9, in, The first time enhancement curve is generated from image data acquired within the blood vessel of interest in a hyperemic state, and the second time enhancement curve is generated from image data within the blood vessel of interest in a resting state, and the blood flow feature is a blood flow reserve determined based on a ratio of corresponding blood flow values ​​calculated from the first time enhancement curve and the second time enhancement curve.

12. The method according to any one of claims 1 to 5, further comprising: include: selecting from the plurality of corresponding images an image that exhibits a maximum contrast enhancement; determining a reference position of the blood vessel of interest in the selected image; as well as The blood vessel of interest is tracked in the plurality of corresponding images based on the reference position.

13. A system for dynamic angiographic imaging, include: a memory for storing CT or MRI image data including a plurality of corresponding images capturing at least a portion of both a ramp-up phase and a ramp-down phase of contrast agent in a vessel of interest; as well as A processor is configured to generate at least one time enhancement curve of the contrast agent based on the CT or MRI image data, the time enhancement curve having an upslope and a downslope; and determine blood flow characteristics in the vessel of interest based on a ratio of the mass of the contrast agent in the vessel of interest to an area under the time enhancement curve.

14. The system of claim 13, in, The CT or MRI image data includes at least one image capturing the blood vessel of interest prior to entry of the contrast agent, and The processor is configured to determine a reference value based on the at least one image capturing the blood vessel of interest before the contrast agent enters, and to normalize the time enhancement curve based on the reference value.

15. The system of claim 13, in, The area under the time enhancement curve is converted into the concentration of the contrast agent in the vessel of interest.

16. The system of claim 14, in, The area under the time enhancement curve is converted into the concentration of the contrast agent in the vessel of interest.

17. The system of claim 13, further comprising an X-ray based CT scanner or MRI scanner configured to acquire scan data of the vessel of interest and reconstruct the CT or MRI image data based on the scan data, the scan data capturing at least a portion of both a rising phase and a falling phase of the contrast agent in the vessel of interest, and in, The plurality of corresponding images is greater than 5 images.

18. The system according to any one of claims 13 to 17, in, The blood flow characteristic is a fractional flow reserve (FFR) value for a hyperemic state or a resting state determined based on the ratio and the Bernoulli equation as expressed as follows:

19. The system of claim 18, in, The FFR is determined at multiple sites within the vessel of interest.

20. The system of any one of claims 13 to 17, in, The blood flow characteristic is a shear stress of the vessel of interest determined based on the ratio, a radius of the vessel of interest, and blood viscosity.

21. The system of any one of claims 13 to 17, in, The at least one time enhancement curve comprises a first time enhancement curve and a second time enhancement curve; as well as Determining the blood flow characteristic includes comparing corresponding values ​​calculated from the first time enhancement curve and the second time enhancement curve.

22. The system of claim 21, in, The first time enhancement curve is generated from image data from a first sampling site located upstream of a suspected source of blood flow abnormality, and the second time enhancement curve is generated from image data from a second sampling site located downstream of the suspected source of the blood flow abnormality.

23. The system of claim 21, in, The first time enhancement curve is generated from image data acquired within the blood vessel of interest in a hyperemic state, and the second time enhancement curve is generated from image data within the blood vessel of interest in a resting state, and the blood flow feature is a blood flow reserve determined based on a ratio of corresponding blood flow values ​​calculated from the first time enhancement curve and the second time enhancement curve.

24. The system of any one of claims 13 to 17, in, The processor is configured to: select an image showing maximum contrast enhancement from the plurality of corresponding images; determine a reference position of the vessel of interest in the selected image; and track the vessel of interest in the plurality of corresponding images based on the reference position.

25. A non-transitory computer readable medium embodying a computer program for dynamic angiographic imaging, include: computer program code for obtaining CT or MRI image data comprising a plurality of corresponding images that capture at least a portion of both a ramp-up phase and a ramp-down phase of contrast agent in a vessel of interest; computer program code for generating at least one time enhancement curve for the contrast agent based on the CT or MRI image data, the time enhancement curve having an upslope and a downslope; as well as Computer program code for determining a blood flow characteristic in the vessel of interest based on a ratio of a mass of the contrast agent in the vessel of interest to an area under the temporal enhancement curve.

26. The non-transitory computer readable medium of claim 25, in, The CT or MRI image data includes at least one image capturing the blood vessel of interest prior to entry of the contrast agent, and The computer readable medium further includes computer program code for determining a reference value based on the at least one image capturing the vessel of interest prior to entry of the contrast agent and normalizing the time enhancement curve based on the reference value.

27. The non-transitory computer readable medium of claim 25, in, The area under the time enhancement curve is converted into the concentration of the contrast agent in the vessel of interest.

28. The non-transitory computer readable medium of claim 26, in, The area under the time enhancement curve is converted into the concentration of the contrast agent in the vessel of interest.

29. The non-transitory computer readable medium of claim 25, further comprising: include: computer program code for acquiring the scan data of the vessel of interest from an X-ray based CT scan or an MRI scan by scanning a subject with a contrast agent to acquire scan data, the scan data capturing at least a portion of both a rising phase and a falling phase of the contrast agent in the vessel of interest; as well as computer program code for reconstructing said CT or MRI image data based on said scan data, and Wherein, the multiple corresponding images are greater than 5 images.

30. The non-transitory computer readable medium of any one of claims 25 to 29, in, Determining the blood flow characteristic includes determining a fractional flow reserve (FFR) value for a hyperemic state or a resting state based on the ratio and using the Bernoulli equation expressed as follows:

31. The non-transitory computer readable medium of claim 30, in, The FFR is determined at multiple sites within the vessel of interest.

32. The non-transitory computer readable medium of any one of claims 25 to 29, in, Determining the blood flow characteristic includes determining a shear stress of the blood vessel of interest based on the ratio, a radius of the blood vessel of interest, and blood viscosity.

33. The non-transitory computer readable medium of any one of claims 25 to 29, in, The at least one time enhancement curve comprises a first time enhancement curve and a second time enhancement curve; as well as Determining the blood flow characteristic includes comparing corresponding values ​​calculated from the first time enhancement curve and the second time enhancement curve.

34. The non-transitory computer readable medium of claim 33, in, The first time enhancement curve is generated from image data from a first sampling site located upstream of a suspected source of blood flow abnormality, and the second time enhancement curve is generated from image data from a second sampling site located downstream of the suspected source of the blood flow abnormality.

35. The non-transitory computer readable medium of claim 33, in, The first time enhancement curve is generated from image data acquired within the blood vessel of interest in a hyperemic state, and the second time enhancement curve is generated from image data within the blood vessel of interest in a resting state, and the blood flow feature is a blood flow reserve determined based on a ratio of corresponding blood flow values ​​calculated from the first time enhancement curve and the second time enhancement curve.

36. The non-transitory computer readable medium of any one of claims 25 to 29, further comprising: include: computer program code for selecting from the plurality of corresponding images an image that exhibits maximum contrast enhancement; computer program code for determining a reference position of the vessel of interest in the selected image; as well as Computer program code for tracking the vessel of interest in the plurality of corresponding images based on the reference location.